baber/WOPTO huggingface dataset:
Patent NZ-544511-A (NZ)
Title: Billing system with authenticated wireless device transaction event data
Inventor: CHANDHOK RAVINDER
IPC: G06Q30/04
Filed: 2004-06-25
Abstract: A method, system, and computer readable medium for utilising authenticated transaction data to generate billing data for wireless devices is disclosed. The system comprises: (a) a wireless network; (b) at least one computer device, each in selective communication with the wireless network and supporting a billable transaction, where each computer device has an associated first key identifying the billable transaction; (c) at least one wireless device, each in selective communication with the wireless network and comprising a computer platform that has an associated second key identifying the wireless device, where each wireless device is capable of conducting a billable transaction with one of the computer devices over the wireless network, and the billable transaction generates authenticable transaction event data on the wireless network; and (d) at least one billing computer in selective communication with the wireless network and gathering at least some of the authenticatable transaction event data for the wireless devices, each for authenticating and aggregating the authenticated transaction event data into transaction event billing data such that each transaction event is billable to the specific wireless device that effected that transaction event, wherein the authenticable transaction event data comprises the first and second keys.
Patent NZ-546498-A (NZ)
Title: Data compression system and method
Inventor: PARKER BRUCE
IPC: H03M7/40
Filed: 2004-10-15
Abstract: A method of compressing a data file is disclosed, where the data file includes a sequence of bytes of a length greater than or equal to a predefined length. The method includes the steps of (a) retrieving the data file (5) from a secondary storage device (10), (b) storing the data file in direct access memory (25), (c) calculating the frequency of unique byte values within a sub-sequence of the data file, where the sub-sequence has a length not exceeding the predefined length, (d) creating an index (65) for the sub-sequence, where the index (65) includes a data value representing the calculated frequency of unique byte values within the sub-sequence, and (e) on the sub-sequence having a frequency of unique byte values below a predetermined threshold, applying a data transformation (40) to the sub-sequence to increase the frequency of unique byte values in the sub-sequence and adding to the index (65) a data value representing the data transformation. On the sub-sequence having a frequency of unique byte values above a predefined threshold, a data value is added to the index (65) representing the position of one or more unique values within the sub-sequence. An output data file (35) is created, where the data file (35) has a file type identifier, and adding the index (65) to the output data file (35).
Patent NZ-548008-A (NZ)
Title: Bone plate
Inventor: BEUTTER FLORIAN
IPC: A61B17/86
Filed: 2003-12-22
Abstract: A bone plate 1, which has the shape of an "X", with an upper side 8, an underside facing the bone, a middle part 2 and, adjoining thereon, a peripheral region 3, which comprises the four arms of the "X" and in which at least four plate boreholes 4 are accommodated, whereby the at least four plate boreholes 4 are disposed at the ends of the four arms of the "X" and at least one of the plate boreholes 4 has anchoring means, which are suitable for the rigid, angularly stable anchoring of bone screws, which are to be introduced therein, whereby the ends of the four arms of the "X" have a width A and are connected to the middle part 2 by connecting regions having a width B, and wherein the width B of the connecting regions is smaller than the width A of the ends of the four arms of the "X".
Patent NZ-550619-A (NZ)
Title: Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament for inhibiting inflammatory effects
Inventor: PETZELBAUER PETER
IPC: C07K14/00
Filed: 2001-12-07
Abstract: Disclosed is the use of a peptide of protein represented by the general formula (I) wherein: R1 and R 2, being equal or different, denote hydrogen, a saturated or unsaturated hydrocarbon moiety comprising from 1 to 10 carbon atoms, wherein a) Z5 denotes a peptide moiety comprising the following amino acid sequence (SEQ ID NO 11): Asp Lys Lys Arg Glu Glu Ala Pro Ser Leu Arg Pro Ala Pro Pro Pro Ile Ser Gly Gly Gly Tyr Arg and  Z1 denotes a histidine moiety Arg denotes an arginine moiety Z3 denotes a proline moiety Z4 denotes a leucine moiety or wherein b) Z5 denotes a peptide moiety comprising the following amino acid sequence (SEQ ID NO 12): Glu Arg His Gln Ser Ala Cys Lys Asp Ser Asp Trp Pro Phe Cys Ser Asp Glu Asp Trp Asn Tyr Lys and  Z1 denotes a proline moiety Arg denotes an arginine moiety Z3 denotes a valine moiety Z4 denotes a valine moiety for the treatment or prevention of local and/or generalised inflammation in the body
Patent NZ-555847-A (NZ)
Title: Methods of selecting host resistant animals
Inventor: SHAW RICHARD JOHN
IPC: A01K67/00
Filed: 2007-06-13
Abstract: Provided is a method of selecting animals that are genetically resistant to one or more intestinal nematode worm infections, said method comprising the steps: (a) obtaining a sample of mucus from said animal; (b) testing the sample for the presence of an antibody specific against a surface antigen present on the third larval stage (L3) of said intestinal nematode worm; and (c) segregating and selecting animals that test positive for the antibody in step (b). Further provided are corresponding methods of diagnosing animals and diagnosis kits.
Patent NZ-556368-A (NZ)
Title: Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
Inventor: LAZZARINI AMERIGA
IPC: A23K20/195
Filed: 2005-01-27
Abstract: Disclosed is a compound of the formula (I) wherein Y1, Y2, Y3, Y4, and Y5 are independently selected from the group consisting of S, S-O-, S=O, O--S=O and O=S=O; and wherein the rest of the substituents are disclosed within the specification. Also disclosed is the use of a compound according to formula (I) for the manufacture of a medicament for the treatment or prevention of bacterial infection.
Patent NZ-562642-A (NZ)
Title: Arrangement for reducing risk in the sale of property
Inventor: SMITH MICHAEL JOHN BARON
IPC: G06Q40/00
Filed: 2006-03-23
Abstract: A computer-based system for selling a property off the plan, by a developer/builder to a purchaser, prior to completion of the property comprising a network; a first computer incorporating a processor and a program comprising code for effecting, over the network, a contract between the developer/builder and the purchaser according to which the developer/builder agrees to complete the property and sell the property to the purchaser for a purchase price; a second computer incorporating a processor and a program comprising code for issuing, over the network, a time-limited, conditional, stand-by undertaking by a finance provider of the purchaser that, if the purchaser does not pay said purchase price in favour of the developer/builder upon completion of the property, a finance provider of the purchaser will pay the purchase price for the benefit of the developer/builder; a third computer incorporating a processor and a program comprising code for accessing, over the network, an electronically accessible register to determine if a right over the undertaking has been registered to another party and a fourth computer incorporating a processor and a program comprising code which, if a said right over the undertaking has not been registered to another party, is configured for providing, over the network, a right over the undertaking to the finance provider of the developer/builder and registering the provided right over the undertaking on the register.
Patent NZ-566276-A (NZ)
Title: Biphenyl derivatives and their use in treating hepatitis C
Inventor: WHEELHOUSE CHRISTOPHER JAMES
IPC: A61K31/381
Filed: 2006-09-18
Abstract: Disclosed are biphenyl compounds of formula (I) or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined in the specification and also there use in treating or preventing a hepatitis C viral (HCV) infection.
Patent NZ-568245-A (NZ)
Title: A lid / stacking spacer for stackable crates
Inventor: JACKSON DAVID KEVIN
IPC: B65D1/00
Filed: 2008-05-13
Abstract: A lid or stacking spacer 1 for a stackable crate is dimensioned to sit or stack on the top of a stackable H crate to form a structural top for the crate, and includes downwardly extending side walls 4 and end walls 5 dimensioned and shaped to be complementary in shape and dimensions to load bearing higher side walls and supporting elements of the H crate(s) with which the spacer is to be used so that product can be placed and stacked on the spacer. The spacer is also strengthened to permit a tie down to be fitted over the spacer and can be used as a pallet for lifting and moving by forklift. The spacer is rotationally or injection moulded from plastics material.
Patent NZ-569936-A (NZ)
Title: 4-(3-Benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives
Inventor: MIYAZAKI KAZUKI
IPC: C07D239/84
Filed: 2007-02-20
Abstract: Disclosed are 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives as represented by the general formula (I) or a salt or hydrate thereof, wherein R represents hydroxyl, alkoxy optionally substituted with alkoxy, or amino optionally substituted with alkyl. Of particular importance are the compounds methyl N-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid, ethyl N-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid, N-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl)phenyl]-N'-methylterephthalamide, isopropyl N-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid, isopropyl N-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl)phenyl]isophthalic acid, N-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4yl)phenyl]terephthalamic acid 2-methoxyethyl ester and N-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl)phenyl]isophthalamic acid 2-methoxyethyl ester. Also disclosed is an antipruritic agent for atopic disease (such as atopic dermatitis), which comprises as an active ingredient, a compound as defined above.
Patent NZ-572042-A (NZ)
Title: Device for maintenance of switchgear including screening plates and a bypass
Inventor: MIKKELSEN PER STEINAR
IPC: H02B1/14
Filed: 2007-05-04
Abstract: Disclosed is a device for maintenance of high-voltage switchgear or fuses in an installation. The device includes screening plates (20A-20C) that are provided with: means for insertion and arrangement (22, 25) of the screening plates in a switchgear cell; means for fastening of the screening plates to the switchgear cell or installation; and means for connection (28A, 28B) of a bypass (27) over switchgear or fuses.
Patent NZ-578518-A (NZ)
Title: Artificial dna sequence with optimized leader function in 5' (5'-utr) for the improved expression of heterologous proteins in plants
Inventor: MARCHETTI STEFANO
IPC: A01H5/00
Filed: 2007-12-27
Abstract: Disclosed is an Artificial DNA sequence of a 5'-UTR leader region (containing one or more copies of the octamer ACAATTAC) effective in enhancing the expression of heterologous proteins in plants, and having elements favourable to gene expression in plants, comprising at least a poly(CAA) region, meaning an oligonucleotide consisting of two or more copies of the CAA element contiguous with each other in combination with at least a poly(CT) region, meaning an oligonucleotide consisting of two or more copies of the CT element contiguous with each other. Further disclosed are bacterial strains and engineered virus strains containing said sequence, and plant cells and plants transformed with expression vectors containing said sequence.
Patent NZ-578647-A (NZ)
Title: Antibodies that bind to p-selectin glycoprotein ligand 1
Inventor: LIN RONG-HWA
IPC: A61K39/395
Filed: 2005-05-10
Abstract: Disclosed is an isolated antibody that binds specifically to amino acid residues 50 to 60 of human P-Selectin Glycoprotein Ligand 1, wherein the antibody, upon binding to P-Selectin Glycoprotein Ligand 1 on an activated T-cell, induces the death of the activated T-cell.
Patent NZ-580887-A (NZ)
Title: Pyridyl piperidine orexin receptor antagonists
Inventor: BRESLIN MICHAEL J
IPC: C07D413/14
Filed: 2008-05-22
Abstract: The disclosure relates to pyridyl piperidine compounds of formula (I), wherein the variables are as defined in the specification. These compounds are antagonists of orexin (hypocretins) receptors, and are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The disclosure is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of diseases in which orexin receptors are involved, such as a sleep disorder.
Patent NZ-585661-A (NZ)
Title: Phenylpyrazole derivatives
Inventor: NAKAMURA TOSHIO
IPC: A61K31/415
Filed: 2008-11-13
Abstract: Disclosed is a phenylpyrazole derivative represented by formula (1) or a pharmaceutically acceptable salt thereof, wherein the substituents are as described within the specification. Examples of compounds of formula (1) include: 4-{ [1-(4-(3-pyrrolidin-1-ylpropoxy)phenyl]-1H-pyrazol-4-yl} carbonyl)morpholine; and 1-(4-{ 3-[(2S)-2-methylpyrrolidin-1-yl]propoxy} phenyl)-1H-pyrazole-4-carboxamide. Further disclosed is the use of a compound of formula (1) in the manufacture of a prophylactic or therapeutic agent for dementia, Alzheimer's disease, attention-deficit hyperactivity disorder, schizophrenia, epilepsy, central convulsion, eating disorders, obesity, diabetes, hyperlipidemia, sleep disorders, narcolepsy, sleep apnea syndrome, circadian rhythm disorder, depression or allergic rhinitis.
Patent NZ-588812-A (NZ)
Title: Gas burner with a venturi tube with a diversion duct to an igntion hole placed downstream of the reduced section of the venturi tube
Inventor: BETTINZOLI ANGELO
IPC: F23Q9/04
Filed: 2008-06-23
Abstract: 588812 Gas burner for oven, or grill, of the type comprising at least a Venturi tube 16, for forming the fuel mixture of primary air - gas, having at least one zone with a reduced section followed by a zone with a diverging section, at least one distribution chamber 17 of the fuel mixture, placed downstream of the zone with a diverging section of the Venturi tube 16, and a plurality of flame openings 19 for the outflow of the fuel mixture, obtained within the distribution chamber 17, or in fluidic communication with the latter, as well at least one ignition hole 13 for igniting the burner, the burner comprising at least one diversion duct 12 for part of the flow of the fuel mixture, with the diversion duct 12 having one inlet and one outlet section. The inlet section of the diversion duct 12 comprises at least one opening obtained on an inner wall of the at least one Venturi tube 16 and/or on an inner wall of the at least one distribution chamber 17. The inlet section is obtained in a sector that is downstream of the zone with a reduced section of the Venturi tube 16. The outlet section of the diversion duct 12 is coincident with the at least one ignition hole 13.
Patent NZ-589575-A (NZ)
Title: Device and method for inserting leaflets into into folded newspapers, the device has pivoting grippers
Inventor: STAUBER HANS ULRICH
IPC: B65G47/22
Filed: 2009-05-25
Abstract: The invention relates to a device and a method for inserting flat objects (5) into a folded printed product (2), wherein the products (2) are held by grippers (12) of a gripper conveyor (10) which opens only briefly for inserting the flat object (5). In order to also stabilize the product in the open state of the gripper (12), according to the invention a support element (22, 22') is provided, which moves between the two product parts (3, 4) before the gripper (12) opens and rests on one of the product parts (3, 4). If the orientations of the support elements (22, 22') and the grippers (12) are selected in a suitable fashion, this will suffice in order to position the product (2) and keep it open such that the flat object (5) can be inserted and the gripper (12) can then be closed again, while clamping the product (2) with the flat object (5) into position. Optionally, further support elements (62, 62', 70) are present, which additionally support the product (2) from the outside, such as the folded edge (6).
Patent NZ-591142-A (NZ)
Title: Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
Inventor: MANLEY PAUL W
IPC: A61K31/506
Filed: 2006-07-18
Abstract: Disclosed are salts of the compound 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide represented by the structural formula shown herein, namely the salts are hydrochloride, monophosphate, diphosphate, sulphate, methane sulfonate, ethane sulfonate, benzene sulfonate, and p-toluene sulfonate salt of said compound. Also disclosed is a method of preparing these salts, and the use of the salt to treat diseases which respond to an inhibition of protein kinase activity.
Patent NZ-591728-A (NZ)
Title: Cephalosporin having catechol group
Inventor: NISHITANI YASUHIRO
IPC: A61K31/5365
Filed: 2009-10-27
Abstract: Disclosed is a cephalosporin compound of formula 1 where the substituents are as disclosed in the specification. Also disclosed is a pharmaceutical composition comprising a compound of formula 1 and the use of a compound of formula 1 in the manufacturing a therapeutic agent for infectious diseases.
Patent NZ-599938-A (NZ)
Title: Novel tricyclic compounds
Inventor: GOEDKEN ERIC R
IPC: A61K31/44
Filed: 2010-12-01
Abstract: The disclosure provides a compound of Formula (Ib) as defined herein, pharmaceutically acceptable salts and stereoisomers thereof wherein the variable are defined herein and one of R1 or R6 must be other than hydrogen. The compounds of the invention are useful for treating immunological and oncological conditions associated with abnormal or deregulated kinase activity. conditions which may be treated with the compounds include: rheumatoid arthritis (RA), systemic onset juvenile rheumatoid arthritis (JRA), Crohn’s disease, psoriasis, psoriatic arthritis, ankylosing spondylitis associated lung disease, and ulcerative colitis. compounds of the disclosure include: 4-(4-(6H-imidazo[1,5-a]pyrrolo[2,3-e]pyrazin-3-yl)phenyl)piperidin-4-ol; 3-(4-hydroxy-4-(4-(1-methyl-6H-imidazo[1,5-a]pyrrolo[2,3-e]pyrazin-3-yl)phenyl)piperidin-1-yl)-3-oxopropanenitrile (1r,4r)-4-(3-(4-(methylsulfonyl)phenyl)-6H-imidazo[1,5-a]pyrrolo[2,3-e]pyrazin-1-yl)cyclohexanamine; 2-((3-(4-(methylsulfonyl)phenyl)-9H-imidazo[1,5-a]pyrrolo[2,3-e]pyrazin-5-yl)methyl)morpholine; 3-(8-methoxyquinolin-5-yl)-1-methyl-6H-imidazo[1,5-a]pyrrolo[2,3-e]pyrazine; and 2-(4-(1-cyclohexyl-6H-imidazo[1,5-a]pyrrolo[2,3-e]pyrazin-3-yl)phenyl)-2-methylpropanenitrile.
Patent NZ-600722-A (NZ)
Title: Thermal and chemical utilization of carbonaceous materials, in particular for emission-free generation of energy
Inventor: RUDLINGER MIKAEL
IPC: C07C29/151
Filed: 2010-11-19
Abstract: Disclosed is a process for the emission-free generation of energy and/or hydrocarbons and other products by utilizing carbon-containing materials, in a first process stage (P1) carbon-containing materials are supplied and pyrolyzed, thereby producing pyrolysis coke (M21) and pyrolysis gas (M22). In a second process stage (P2), the pyrolysis coke (M21) from the first process stage (P1) is gasified, thereby producing synthesis gas (M24), and slag and other residual materials (M91, M92, M93, M94) are removed. In a third process stage (P3), the synthesis gas (M24) from the second process stage (P2) is converted into hydrocarbons and/or other solid, liquid and/or gaseous products (M60), which are discharged. The three process stages (P1, P2, P3) form a closed cycle. Excess gas (M25) from the third process stage (P3) is conducted as recycled gas into the first process stage (P1) and/or the second process stage (P2), and the pyrolysis gas (M22) from the first process stage (P1) is conducted into the second process stage (P2) and/or the third process stage (P3); wherein hydrogen is supplied in the third process stage and carbon dioxide is supplied in the first process stage or second process stage. Preferably, the heat energy for the pyrolysis reactions in the first process stage is provided in part or completely by returning a 20 part of the hot synthesis gas from the second process stage into the first process stage, and/or by partial oxidation of the carbonaceous starting material and the resultant pyrolysis coke.
Patent NZ-601237-A (NZ)
Title: Container
Inventor: PUDSELYKKE LARS
IPC: B65D43/02
Filed: 2011-01-07
Abstract: 601237 A container is disclosed comprising a number of side walls that meet at corners and a detachable lid. An outward directed ridge of the opening engages with an inward directed ridge of the lid. The lid is provided with a skirt below the engagement portion at the corners where at least one of the curved corner sections is provided with a bendable skirt section (12) adapted to be bent in such a way that a curved section of the inward directed ridge is levered away from the outward directed ridge. The bendable skirt section (12) is separated from the remaining part of the skirt (9) by at least two grooves (22), cuts or pre-cuts formed in the outside surface of the skirt (9) in order to allow the bendable skirt section (12) to bend.
Patent NZ-602358-A (NZ)
Title: Reinforced plastic containers
Inventor: YOURIST SHELDON E
IPC: B65D1/44
Filed: 2011-03-18
Abstract: A plastic container 10, comprises a bottom portion, and a main body portion 10 with a plastic sidewall 14 that is connected to the bottom portion. The main body portion has a reinforced sidewall area that comprises a plurality of first sidewall portions 20 and a plurality of second sidewall portions 22 that are respectively interposed between the first sidewall portions 20. The entirety of each of the second sidewall portions 22 is recessed with respect to the adjacent first sidewall portions 20 and extends circumferentially about the main body portion. Each of the second sidewall portions 22 is further shaped to define a plurality of alternating concave indentations 26 and convex projections 34 as viewed in transverse cross-section.
Patent NZ-608927-A (NZ)
Title: Tissue sampling device
Inventor: CORBETT GEOFFREY EARLE
IPC: G01N1/00
Filed: 2011-12-02
Abstract: Disclosed are a container (15) and sample punch (11) for use with a tissue sampling device to retain a tissue sample (30) and an apparatus for tissue sampling. The disclosure notes that animal tissue samples are often taken to test DNA of animals and multiple samples can be taken at one time. It is important that there is no cross-contamination between samples and that the tissue sampling device only causes the animal to suffer a minimum amount of trauma. The container (15) and sample punch (11) comprise a container body (21) and an anvil (22). The container body (21) retains the tissue sample (30) and includes an open end (16). The anvil (22) is located at the open end (16) of the container body (21). An external portion of the container (15) has a shape to facilitate support of the container during excision of the tissue sample (30). The sample punch (11) has an excising edge shaped and dimensioned to be driven against the anvil (22) to excise the tissue sample (30).